تينوفوفير ديسوبروكسيل فومارات
| Kind | API |
|---|---|
| Class | Antiviral — nucleotide reverse transcriptase inhibitor (NtRTI) |
| Synonyms | TDF, Tenofovir DF, Bis(POC)-PMPA fumarate, PMPA prodrug |
| Common uses / forms | Oral tablets for HIV-1 and chronic hepatitis B; backbone of fixed-dose combinations (with lamivudine/emtricitabine, efavirenz, or dolutegravir as TLD) |
| Properties | BCS Class III (high solubility, low permeability); disoproxil di-ester prodrug of tenofovir; hygroscopic and hydrolysis-sensitive with a low melting point; tight moisture control required |
| Compendia | USP, EP, BP, IP |
| Sourcing origins | India, China |
| Dominant inbound route | Hormuz |
| Indicative price band | $$ ($10–100 / kg) |
| Indicative lead time | medium (50–80 days) |
| Notes | Moisture-sensitive prodrug; monoester and free-tenofovir degradants need tight limits; dominant multi-source Indian generic API |
Open the interactive Data Bank (363 substances) · the full table · Supply Resilience Studio
Share: LinkedIn · X · WhatsApp · Telegram · Email
Cite as: AUPAM Experts' Office, Tenofovir disoproxil fumarate — sourcing profile (API) — AUPAM Data Bank, retrieved 2026-08-31, https://aupameo.org/datasets/databank/a-tenofovir-disoproxil-fumarate.html